Postmarketing surveillance of adverse reactions to drugs.
- 24 March 1984
- Vol. 288 (6421) , 879-880
- https://doi.org/10.1136/bmj.288.6421.879
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Erythromycin estolate and jaundice.BMJ, 1983
- Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.BMJ, 1983
- Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.BMJ, 1983
- The Use of Vital and Morbidity Statistics for the Detection of Adverse Drug Reactions and for Monitoring of Drug SafetyThe Journal of Clinical Pharmacology, 1982
- BRAND NAMES, APPROVED NAMES, AND DRUG SAFETYThe Lancet, 1982
- Post-marketing surveillance of adverse reactions to new medicines.BMJ, 1977
- Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"?BMJ, 1977